In vivo manufacture and manipulation of CAR-T cells for better druggability
Rui Hou(Xuzhou Medical College), Ming Shi(Southwest Jiaotong University), Jiang Cao(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College), Dan Liu(Nanjing University of Chinese Medicine), Xuan Zhao(Xuzhou Medical College), Xiaoxue Zhang(Xuzhou Medical College), Sijin Li(Xuzhou Medical College), Xu Wang(HudsonAlpha Institute for Biotechnology), Zhangchun Guan
Cited by 18
Related Papers
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136
CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation
|Cell Death and Differentiation|2014|116